<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699437</url>
  </required_header>
  <id_info>
    <org_study_id>HME</org_study_id>
    <nct_id>NCT02699437</nct_id>
  </id_info>
  <brief_title>Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia</brief_title>
  <official_title>Prevalence of Antiphospholipid Antibodies Among Women With Preeclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Sayed Abdelhafez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the prevalence of positive antiphospholipid
      antibodies among women with preeclampsia and to determine the effect of antiphospholipid
      antibodies on the severity of preeclampsia and the obstetric outcomes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For all women included in the study, blood samples will be tested for anticardiolipin
      antibodies and lupus anticoagulant. The clinical details of all women will be collected by
      reviewing their hospital and prenatal records. The following clinical characteristics will be
      evaluated: maternal age, previous gestations, parity, past or family history of preeclampsia,
      gestational age at the onset of preeclampsia, gestational age at delivery and birth weight.
      The following pregnancy and delivery complications will be assessed: placental insufficiency,
      intrauterine growth restriction, fetal loss (stillbirth) and early neonatal death.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of positive antiphospholipid antibodies</measure>
    <time_frame>20 weeks to 42 weeks gestational age</time_frame>
    <description>Number of women having positive antiphospholipid antibodies per total number of women</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>Pregnant women with preeclampsia</arm_group_label>
    <description>Testing for antiphospholipid antibodies (anticardiolipin antibodies and lupus anticoagulant) will be performed in pregnant women with preeclampsia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Testing for antiphospholipid antibodies</intervention_name>
    <description>Blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant</description>
    <arm_group_label>Pregnant women with preeclampsia</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples will be tested for anticardiolipin antibodies and lupus anticoagulant
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Attendants of Tertiary Hospital Obstetric Outpateint Clinics and Emergency Department
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women with preeclampsia.

        Exclusion Criteria:

          -  Women with systemic autoimmune disease.

          -  Women with active thromboembolic disorders.

          -  Women with history of previous thromboembolic disorders.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanaa M El-Shafiey</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed S Abdelhafez, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alaa El-Din M El-Gohary, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>El-Said M Abd El-Hady, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanaa M El-Shafiey</last_name>
    <email>hanaamohamed.80@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Obstetrics and Gynecology Department in Mansoura University Hospital</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>February 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Sayed Abdelhafez</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Preeclampsia</keyword>
  <keyword>Antiphospholipid Antibodies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
    <mesh_term>Antibodies, Antiphospholipid</mesh_term>
    <mesh_term>Antibodies, Anticardiolipin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

